New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma.
New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma.
复制标题
DOI:
10.7150/ijms.11047
复制
发表时间:
2015
影响因子:
3.6
通讯作者:
Heiss JD
中科院分区:
文献类型:
--
作者:
Dimitrov L;Hong CS;Yang C;Zhuang Z;Heiss JD
In the last five years, IDH1 mutations in human malignancies have significantly shaped the diagnosis and management of cancer patients. Ongoing intense research efforts continue to alter our understanding of the role of the IDH1 mutation in tumor formation. Currently, evidence suggests the IDH1 mutation to be an early event in tumorigenesis with multiple downstream oncogenic consequences including maintenance of a hypermethylator phenotype, alterations in HIF signalling, and disruption of collagen maturation contributing to a cancer-promoting extracellular matrix. The most recent reports elucidating these mechanisms is described in this review with an emphasis on the pathogenesis of the IDH1 mutation in glioma. Conflicting findings from various studies are discussed, in order to highlight areas warranting further research. Finally, the latest progress in developing novel therapies against the IDH1 mutation is presented, including recent findings from ongoing phase 1 clinical trials and the exciting prospect of vaccine immunotherapy targeting the IDH1 mutant protein.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
50.3
作者:
Figueroa ME;Abdel-Wahab O;Lu C;Ward PS;Patel J;Shih A;Li Y;Bhagwat N;Vasanthakumar A;Fernandez HF;Tallman MS;Sun Z;Wolniak K;Peeters JK;Liu W;Choe SE;Fantin VR;Paietta E;Löwenberg B;Licht JD;Godley LA;Delwel R;Valk PJ;Thompson CB;Levine RL;Melnick A
通讯作者:
Melnick A
影响因子:
15.9
作者:
Dolecek, Therese A.;Propp, Jennifer M.;Kruchko, Carol
通讯作者:
Kruchko, Carol
影响因子:
3.5
作者:
DALZIEL, K
通讯作者:
DALZIEL, K
影响因子:
28.2
作者:
Elhammali A;Ippolito JE;Collins L;Crowley J;Marasa J;Piwnica-Worms D
通讯作者:
Piwnica-Worms D